Join to View Full Profile
- UK Medical Oncology800 Rose Street CC401 Roach BuildingLexington, KY 40536 
- Phone+1 859-323-6522 
- Fax+1 859-257-3757 
Dr. Villano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 University of ChicagoFellowship, Hematology and Medical Oncology, 2001 - 2004 University of ChicagoFellowship, Hematology and Medical Oncology, 2001 - 2004
 Cook County Health and Hospitals SystemResidency, Internal Medicine, 1999 - 2001 Cook County Health and Hospitals SystemResidency, Internal Medicine, 1999 - 2001
 University of MichiganResidency, Neurology, 1998 - 1999 University of MichiganResidency, Neurology, 1998 - 1999
 University of Texas Southwestern Medical SchoolClass of 1997 University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
 KY State Medical License 2011 - 2026 KY State Medical License 2011 - 2026
 FL State Medical License 2015 - 2017 FL State Medical License 2015 - 2017
 IL State Medical License 1999 - 2017 IL State Medical License 1999 - 2017
 MI State Medical License 1998 - 1999 MI State Medical License 1998 - 1999
 American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Internal Medicine
 American Board of Internal Medicine Medical Oncology American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
- Post-approval Study of NovoTTF-100A in Recurrent GBM Patients Start of enrollment: 2012 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Novel desensitization protocol utilizing conventional formulations to mitigate Temozolomide-Related skin hypersensitivity.Morgan E Cantley, Clyde Coleman, Rachael M Morgan, Niharika Reddy, Sarah A Sertich
 Cancer Chemotherapy and Pharmacology. 2025-06-20
- Dihydropyrimidine enzyme activity and its effect on chemotherapy toxicity: importance of genetic testing.Alexia Shamaei Zadeh, Danielle Roberts, Abby Williams, Deepali Pandey, John L Villano
 Cancer Chemotherapy and Pharmacology. 2025-01-18
- 3 citationsOutcomes of Brain Metastasis from Lung Cancer.James M Mobley, Kerry I Phillips, Quan Chen, Ellen Reusch, Niharika Reddy
 Cancers. 2025-01-14
Press Mentions
 Markey Researchers Identify Genetic Marker That Could Guide Brain Cancer TreatmentJuly 25th, 2025 Markey Researchers Identify Genetic Marker That Could Guide Brain Cancer TreatmentJuly 25th, 2025
 Ky. Attorney Defies Brain Cancer Odds Through Markey Clinical TrialMay 15th, 2025 Ky. Attorney Defies Brain Cancer Odds Through Markey Clinical TrialMay 15th, 2025
 Brain Cancer Awareness: Understanding the Signs, Risks and TreatmentsMay 5th, 2025 Brain Cancer Awareness: Understanding the Signs, Risks and TreatmentsMay 5th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










